1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Tao W, Cheng YX, Zou YY, Peng D and Zhang
W: Aorta calcifification increases the risk of anastomotic leakage
after gastrectomy in gastric cancer patients. Cancer Manag Res.
13:3857–3865. 2021.PubMed/NCBI View Article : Google Scholar
|
3
|
Shirani M, Pakzad R, Haddadi MH, Akrami S,
Asadi A, Kazemian H, Moradi M, Kaviar VH, Zomorodi AR, Khoshnood S,
et al: The global prevalence of gastric cancer in Helicobacter
pylori-infected individuals: A systematic review and meta-analysis.
BMC Infect Dis. 23(543)2023.PubMed/NCBI View Article : Google Scholar
|
4
|
An international association between
Helicobacter pylori infection and gastric cancer. The EUROGAST
Study Group. Lancet. 341:1359–1362. 1993.PubMed/NCBI
|
5
|
Saeedi P, Salpea P, Karuranga S, Petersohn
I, Malanda B, Gregg EW, Unwin N, Wild SH and Williams R: Mortality
attributable to diabetes in 20-79 years old adults, 2019 estimates:
Results from the International Diabetes Federation Diabetes Atlas,
9th edition. Diabetes Res Clin Pract. 162(108086)2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Garza-Campos A, Prieto-Correa JR,
Domínguez-Rosales JA and Hernández-Nazará ZH: Implications of
receptor for advanced glycation end products for progression from
obesity to diabetes and from diabetes to cancer. World J Diabetes.
14:977–994. 2023.PubMed/NCBI View Article : Google Scholar
|
7
|
Mazzone T: Intensive glucose lowering and
cardiovascular disease prevention in diabetes: Reconciling the
recent clinical trial data. Circulation. 122:2201–2211.
2010.PubMed/NCBI View Article : Google Scholar
|
8
|
Emerging Risk Factors Collaboration.
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio
E, Ingelsson E, Lawlor DA, Selvin E, et al: Diabetes mellitus,
fasting blood glucose concentration, and risk of vascular disease:
A collaborative metaanalysis of 102 prospective studies. Lancet.
375:2215–2222. 2010.PubMed/NCBI View Article : Google Scholar
|
9
|
Yang HJ, Kang D, Chang Y, Ahn J, Ryu S,
Cho J, Guallar E and Sohn CI: Diabetes mellitus is associated with
an increased risk of gastric cancer: A cohort study. Gastric
Cancer. 23:382–390. 2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Miao ZF, Xu H, Xu YY, Wang ZN, Zhao TT,
Song YX and Xu HM: Diabetes mellitus and the risk of gastric
cancer: A meta-analysis of cohort studies. Oncotarget.
8:44881–44892. 2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Ikeda F, Doi Y, Yonemoto K, Ninomiya T,
Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M and
Kiyohara Y: Hyperglycemia increases risk of gastric cancer posed by
Helicobacter pylori infection: A population-based cohort study.
Gastroenterology. 136:1234–1241. 2009.PubMed/NCBI View Article : Google Scholar
|
12
|
Wei ZW, Li JL, Wu Y, Xia GK, Schwarz RE,
He YL and Zhang CH: Impact of pre-existing type-2 diabetes on
patient outcomes after radical resection for gastric cancer: A
retrospective cohort study. Dig Dis Sci. 59:1017–1024.
2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen X, Chen Y, Li T, Jun L, Lin T, Hu Y,
Huang H, Chen H, Liu H, Li T, et al: Impact of diabetes on
prognosis of gastric cancer patients performed with gastrectomy.
Chin J Cancer Res. 32:631–644. 2020.PubMed/NCBI View Article : Google Scholar
|
14
|
Rubin DB and Thomas N: Matching using
estimated propensity scores: Relating theory to practice.
Biometrics. 52:249–264. 1996.PubMed/NCBI
|
15
|
Rubin DB: The design versus the analysis
of observational studies for causal effects: Parallels with the
design of randomized trials. Stat Med. 26:20–36. 2007.PubMed/NCBI View
Article : Google Scholar
|
16
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred Reporting Items for Systematic Reviews
and Meta-Analyses: The PRISMA Statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
17
|
Wells GA, O'Connell D and Peterson J: The
Newcastle-Ottawa scale (NOS) for assessing the quality of
nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Accessed Nov 1, 2011.
|
18
|
Admiraal WM, Celik F, Gerdes VE, Dallal
RM, Hoekstra JB and Holleman F: Ethnic differences in weight loss
and diabetes remission after bariatric surgery: A meta-analysis.
Diabetes Care. 35:1951–1958. 2012.PubMed/NCBI View Article : Google Scholar
|
19
|
Matsui R and Inaki Nand Tsuji T: Impact of
diabetes mellitus on long-term prognosis after gastrectomy for
advanced gastric cancer: A propensity score matching analysis. Surg
Today. 28(1382)2022.PubMed/NCBI View Article : Google Scholar
|
20
|
Sheng L, Peng H, Pan Y, Wang C and Zhu Y:
Evaluating the effect of diabetes on the prognosis of gastric
cancer using a propensity score matching method. J Gastrointest
Oncol. 11:999–1008. 2020.PubMed/NCBI View Article : Google Scholar
|
21
|
Cheng YX, Tao W, Kang B, Liu XY, Yuan C,
Zhang B and Peng D: Impact of preoperative type 2 diabetes mellitus
on the outcomes of gastric cancer patients following gastrectomy: A
propensity score matching analysis. Front Surg.
9(850265)2022.PubMed/NCBI View Article : Google Scholar
|
22
|
Tian T, Zhang LQ, Ma XH, Zhou JN and Shen
J: Diabetes mellitus and incidence and mortality of gastric cancer:
A meta-analysis. Exp Clin Endocrinol Diabetes. 120:217–223.
2012.PubMed/NCBI View Article : Google Scholar
|
23
|
Coughlin SS, Calle EE, Teras LR, Petrelli
J and Thun MJ: Diabetes mellitus as a predictor of cancer mortality
in a large cohort of US adults. Am J Epidemiol. 159:1160–1167.
2004.PubMed/NCBI View Article : Google Scholar
|
24
|
Marimuthu SP, Vijayaragavan P, Moysich KB
and Jayaprakash V: Diabetes mellitus and gastric carcinoma: Is
there an association? J Carcinog. 10(30)2011.PubMed/NCBI View Article : Google Scholar
|
25
|
Zylla D, Gilmore G, Eklund J, Richter S
and Carlson A: Impact of diabetes and hyperglycemia on health care
utilization, infection risk, and survival in patients with cancer
receiving glucocorticoids with chemotherapy. J Diabetes
Complications. 33:335–339. 2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Lee KC, Chung KC, Chen HH, Cheng KC, Wu
KL, Song LC and Hu WH: The impact of comorbid diabetes on
short-term postoperative outcomes in stage I/II colon cancer
patients undergoing open colectomy. Biomed Res Int.
2020(2716395)2020.PubMed/NCBI View Article : Google Scholar
|
27
|
Lega IC and Lipscombe LL: Review:
Diabetes, obesity and cancer-pathophysiology and clinical
implications. Endocr Rev. 41(bnz014)2020.PubMed/NCBI View Article : Google Scholar
|
28
|
Ohara N, Kobayashi M, Ikeda Y, Hoshi T,
Morita S, Kanefuji T, Yagi K, Suda T, Takada T, Hasegawa G, et al:
Non-insulin-dependent diabetes mellitus induced by immune
checkpoint inhibitor therapy in an insulinoma-associated antigen-2
autoantibody-positive patient with advanced gastric cancer. Intern
Med. 59:551–556. 2020.PubMed/NCBI View Article : Google Scholar
|
29
|
Guo J, Liu C, Pan J and Yang J:
Relationship between diabetes and risk of gastric cancer: A
systematic review and meta-analysis of cohort studies. Diabetes Res
Clin Pract. 187(109866)2022.PubMed/NCBI View Article : Google Scholar
|
30
|
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh
KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al: Screening
for gastric cancer in Asia: Current evidence and practice. Lancet
Oncol. 9:279–287. 2008.PubMed/NCBI View Article : Google Scholar
|
31
|
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M and
Samet JM: Fasting serum glucose level and cancer risk in Korean men
and women. JAMA. 293:194–202. 2005.PubMed/NCBI View Article : Google Scholar
|
32
|
Koskinen SV, Reunanen AR, Martelin TP and
Valkonen T: Mortality in a large population-based cohort of
patients with drug-treated diabetes mellitus. Am J Public Health.
88:765–770. 1998.PubMed/NCBI View Article : Google Scholar
|